America Handing MRNA Lead: Investors Reassess Biotech
A political shift in the United States is denting confidence in mRNA medicine, with funding drying up and manufacturi...
Compare Target Date versus Index options in 401(k) plans, highlighting cost, diversification, and adaptability. Learn which fund type best fits your retirement timeline.
25,660 articlesA political shift in the United States is denting confidence in mRNA medicine, with funding drying up and manufacturi...
Meta has slashed about 25,000 jobs since 2022, with 700 more in Reality Labs this week. The moves spotlight a leaders...
A SpaceX IPO could reshape growth investing, creating upside for Rivian and other high-growth names. This guide break...
DraftKings reports a mixed Q1 2026 while signaling growth hinges on prediction markets and regulatory clarity. A path...
A new study from Northwestern Mutual finds 40% of Americans expect to work through retirement, but the reasons split ...
Domain Money is expanding as investors seek integrated, CFP-guided planning powered by AI tools amid market volatilit...
SpaceX’s Grok AI platform posted solid revenue yet massive losses in the latest quarter, raising questions about the ...
Mid-career jobseekers are trimming resumes and curating online profiles as hiring cools and AI filters tighten. The t...
Bitcoin remains volatile as ETF outflows and higher rates weigh on demand. This report weighs the case for worth inve...
Crypto chatbots guide users through volatile markets, but a hidden threat called what prompt injection attack? can hi...
HIVE Blockchain posted a standout revenue gain for the year, even as its bitcoin stash declined to 150 BTC, highlight...
A note from Standard Chartered suggests bitcoin's bottom could be in sight after a tough week, driven by steady ETF d...